Value-based care is transforming the world of healthcare. Simple cost management must give way to utilization management, and alignment of stakeholder services is inevitable.
Pharmacists need to unionize. You've heard all the reasons. Here's another one -- and it's time-sensitive.
For patients, preventive services are a vital healthcare resource. For the healthcare delivery system, they produce cost savings. Pharmacists are a key link.
The combination product is indicated to treat either complicated intra-abdominal infections, where it is used in combination with metronidazole, or complicated urinary tract infections in patients with few or no other treatment options.
It can take years to establish the safety and efficacy of new drug therapies. What should we do in the meantime?
In Part 3 of "The New Pharmacy," Mark Burger takes you through the daily checklist of a successful practice.
R&D and product manufacture are only the beginning. When the time comes to enter the marketplace, biosimilars still face numerous obstacles.
Selexipag is a first-in-class oral treatment option to reduce progression and hospitalization for pulmonary arterial hypertension.
Where things stand, where they're headed, and what you need to do now.
If you want improved working conditions in the pharmacy, you're gonna hafta help.
Once we as individuals in the healthcare profession finally begin to accept addiction as a disease and not a moral failing, the affected individuals will have a better chance at recovery and we will gain a better understanding of this epidemic.
Tomorrow's pharmacists and pharmacies will need to find ways to increase profit margins by reducing the cost of prescribing, embracing technology, and focusing more on patient counseling, immunizations, education, and other offshoots of their clinical expertise.
Specialty pharmacies are developing to meet the growing needs of children and senior citizens.
During the American Association of Colleges of Pharmacy (AACP) Annual Meeting in Kissimmee, Fla. in mid-July, Jill Fitzgerald, PharmD, who is Drug Topics CPE accreditor, was sworn in as chair-elect to the AACP Continuing Professional Education Section.
Categories to watch in this year's diverse drug pipeline include oral agents to treat multiple sclerosis and a host of new diabetes, cardiovascular, and pain-management products.
Increasing enrollment in pharmacy schools and changing economic factors appear to have eased the national pharmacist shortage. In order to plan appropriately for all stakeholders, we need to quantify the numbers when we talk about a pharmacist shortage.